about
Insulin-like growth factor 1Adiponectin, C1Q and collagen domain containingDystrophin, muscular dystrophyC-abl oncogene 1, non-receptor tyrosine kinaseAngiotensin I converting enzyme (peptidyl-dipeptidase A) 2Phosphatase and tensin homologLeukemia inhibitory factorSMAD family member 4Toll-like receptor 4LYN proto-oncogene, Src family tyrosine kinaseLIM domain only 3EPH receptor B2Chromosome 3 open reading frame 33Rap guanine nucleotide exchange factor 1CNKSR family member 3DAB2 interacting proteinC-terminal Src kinaseDual specificity phosphatase 3Dual specificity phosphatase 4Dual specificity phosphatase 6Dual specificity phosphatase 10NDRG family member 2Cholinergic receptor nicotinic alpha 10 subunitArrestin beta 1Crystallin beta A1Sprouty RTK signaling antagonist 1Sprouty RTK signaling antagonist 2Cholinergic receptor, nicotinic, alpha polypeptide 7Cholinergic receptor nicotinic alpha 9 subunitDual specificity phosphatase 26RAN binding protein 9SLC9A3 regulator 1Butyrophilin subfamily 2 member A2Discs large MAGUK scaffold protein 1Kruppel like factor 4Integrin subunit beta 1 binding protein 1Sprouty RTK signaling antagonist 4Peptidylprolyl cis/trans isomerase, NIMA-interacting 1TIMP metallopeptidase inhibitor 3TNFAIP3 interacting protein 1
P682
Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activationPharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathwaysAC3-33, a novel secretory protein, inhibits Elk1 transcriptional activity via ERK pathwayProhibitin is involved in the activated internalization and degradation of protease-activated receptor 1RanBPM is an inhibitor of ERK signalingA new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signalingReciprocal regulation of extracellular signal regulated kinase 1/2 and mitogen activated protein kinase phosphatase-3Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2
P921
Q14863723-EFA7EB1C-5368-414B-A11D-0543148D776CQ14864062-CDC69A85-F1DE-427E-9BC8-9E377EDD0FEEQ14864296-9BD7167E-DCAD-491E-894F-24143205F36FQ14874000-67A39F18-8BA4-48EE-BECD-1207F2887690Q14875366-485419F3-1AC0-4502-894A-9181FD623EB0Q14878408-4C1693BE-41B5-440B-A8A0-DE70D6634761Q14878799-9C8F3A8D-9B4A-476C-861F-0B9F1E2065BAQ14904159-2651FCEA-3A1B-4C31-B8E3-07782607B10DQ14914104-3E1551BA-8993-4431-8306-E00B4136AF61Q15331919-7A76A082-A0CE-456E-B960-1B8ECF85860DQ21100404-8E0ABF64-220C-414D-98C1-8C8BCED9DDD3Q21101182-4755D18E-A8EF-4DE8-9117-73FA2C6BD038Q21102229-1916F805-483B-4EAA-A5FB-A225C67BAB56Q21104809-E836676D-CDD7-4322-AC86-5B141E9F53DCQ21105664-06CA5A4E-BA1E-4893-86D1-1D2CA8713BAFQ21105664-CC68B080-6F31-409D-A149-A0E095560F2DQ21105736-E51984BD-03E2-4B30-879E-CABD2D8A9889Q21106978-6BDB6D6B-6018-4A28-AC09-FBFEA5B1FF39Q21107149-07E9B03C-6EAC-4474-94BD-8A4E83EDCE6DQ21107149-A5FA26CE-497F-487E-B795-FE0CB131998FQ21107153-259A1965-C238-42C6-95D5-8959D6429253Q21107163-4D4E8CC7-2A26-474A-9EFF-C9E132D90D28Q21107163-7284BE1F-9E27-45FE-B398-EACB3400BAD5Q21107243-B4299936-97A1-4C13-B4D4-25D43A562E04Q21107321-B03F4F10-6621-4420-9D6B-34D6F645F8ADQ21108135-EACCD835-B60B-432B-AC9A-EEC41301FE4DQ21109259-62FBD66D-88DB-45CD-AF0E-94A674870649Q21109919-B9EB6C15-B352-4B71-B99A-852A8D29B4C5Q21110791-171325AC-5898-48EA-A893-F07EC4923C47Q21111117-7CB76549-6FD0-401D-9573-AE985FC894A3Q21111117-E744CF7D-5EA6-4719-839C-22068D585F48Q21111177-E4A2768E-F246-44D2-9AB2-CA435C017EC6Q21111184-06D2987F-951A-4D7C-90CE-FD77C31A2889Q21111841-ED447446-9D89-4D45-A4CC-421D48CA4960Q21112197-BEB5B5A6-9BD7-4706-AB2A-743695794008Q21112493-4149D272-82D7-410B-BD1C-9FA94970C4E7Q21112872-234AA236-B6AA-4C87-8E44-EDDB795605FCQ21113813-CA4C9BC8-B3F6-4FAF-B8CE-A04811456E93Q21114206-9A71498E-D9FC-4F25-B793-6752B2EA749BQ21114501-89D639CF-E9F8-477D-807A-826BB8D56317
P682
Q24290536-7BD235D2-3D01-40D2-9E05-349F37F434AAQ24291330-8FE9A9FF-8113-4609-BD81-82121666810AQ24294305-CA1E17EE-4A88-4A3C-9315-1AB0A0630965Q24294667-4DC52119-66F5-4835-868A-7FEE2C29E2EBQ24302200-70148E2B-DB16-4D5B-AD3B-A0C2C6A7A8B5Q24306371-6B18C81E-7615-4AAC-892C-2D99F0F5A086Q24310324-ECBB5DDC-39A3-4D14-A18A-C43892092097Q24313003-7928E144-AB78-4321-9054-AFAF42D3CAC8Q24323910-078794C7-FC02-42D3-9506-B80B57C6F7B6
P921
description
Any process that stops, preven ...... by the ERK1 and ERK2 cascade.
@en
biologisch proces
@nl
name
negative regulation of ERK1 and ERK2 cascade
@en
type
label
negative regulation of ERK1 and ERK2 cascade
@en
altLabel
GO:0070373
@en
down regulation of ERK1 and ERK2 cascade
@en
down-regulation of ERK1 and ERK2 cascade
@en
downregulation of ERK1 and ERK2 cascade
@en
negative regulation of ERK1 and ERK2 signaling pathway
@en
negative regulation of ERK1 and ERK2 signalling pathway
@en
negative regulation of ERK1/2 cascade
@en
prefLabel
negative regulation of ERK1 and ERK2 cascade
@en
P2888
P686
GO:0070373